Team:Peking R/HumanPractice

From 2011.igem.org

(Difference between revisions)
Line 11: Line 11:
position:absolute;
position:absolute;
left:53px;
left:53px;
-
top:318px;
+
top:319px;
-
width:640px;
+
width:655px;
-
height:1852px;
+
height:1723px;
-
z-index:1;
+
z-index:2;
font-family: "Comic Sans MS", cursive;
font-family: "Comic Sans MS", cursive;
font-size: 14px;
font-size: 14px;
Line 22: Line 22:
}
}
.notbookmaintitle {
.notbookmaintitle {
-
font-size: 30px;
+
font-size: 24px;
font-family: "Arial Black", Gadget, sans-serif;
font-family: "Arial Black", Gadget, sans-serif;
color: #000;
color: #000;
font-weight: bold;
font-weight: bold;
 +
text-align: center;
}
}
.name {
.name {
Line 69: Line 70:
color: #000;
color: #000;
text-align: left;
text-align: left;
 +
font-weight: bold;
}
}
#apDiv1 table tr .notbookmaintitle {
#apDiv1 table tr .notbookmaintitle {
Line 75: Line 77:
}
}
.Julytitle {
.Julytitle {
-
font-family: Verdana, Geneva, sans-serif;
+
font-family: "Arial Black", Gadget, sans-serif;
text-align: left;
text-align: left;
font-size: 24px;
font-size: 24px;
Line 106: Line 108:
}
}
.clickteam {
.clickteam {
-
color: #060;
+
color: #000;
}
}
a:link {
a:link {
-
color: #060;
+
color: #093;
text-decoration: none;
text-decoration: none;
}
}
Line 122: Line 124:
a:active {
a:active {
text-decoration: none;
text-decoration: none;
-
color: #090;
+
font-size: 10px;
}
}
#apDiv4 {
#apDiv4 {
position:absolute;
position:absolute;
-
left:64px;
+
left:77px;
-
top:385px;
+
top:527px;
-
width:610px;
+
width:599px;
-
height:1209px;
+
height:3555px;
-
z-index:2;
+
z-index:3;
text-align: justify;
text-align: justify;
 +
color: #000;
}
}
.mainbody {
.mainbody {
text-align: justify;
text-align: justify;
color: #333;
color: #333;
-
font-weight: bold;
 
}
}
.main {
.main {
-
color: #093;
+
color: #063;
font-weight: bold;
font-weight: bold;
}
}
.clickteam #apDiv4 .download .mainbody {
.clickteam #apDiv4 .download .mainbody {
text-align: justify;
text-align: justify;
 +
}
 +
#apDiv5 {
 +
position:absolute;
 +
left:61px;
 +
top:2312px;
 +
width:610px;
 +
height:687px;
 +
z-index:4;
 +
}
 +
#apDiv6 {
 +
position:absolute;
 +
left:374px;
 +
top:492px;
 +
width:335px;
 +
height:29px;
 +
z-index:4;
 +
}
 +
.clickteam #apDiv6 table {
 +
font-size: 12px;
}
}
</style>
</style>
Line 150: Line 171:
<body class="clickteam">
<body class="clickteam">
<div id="apDiv1">
<div id="apDiv1">
-
   <p class="notbookmaintitle">  &nbsp;&nbsp; &nbsp;   &nbsp; &nbsp;&nbsp;  Human Practice Home</p>
+
   <p class="notbookmaintitle">  Investigation of Antibiotic Use and</p>
 +
  <p class="notbookmaintitle"> Related Biosafety Issues: What's </p>
 +
  <p class="notbookmaintitle">happening out there and further. </p>
 +
   <p class="notbookmaintitle">&nbsp;</p>
 +
  <hr />
   <p class="notbookmaintitle">&nbsp;</p>
   <p class="notbookmaintitle">&nbsp;</p>
   <p>&nbsp;</p>
   <p>&nbsp;</p>
Line 195: Line 220:
   <p>&nbsp;</p>
   <p>&nbsp;</p>
   <p>&nbsp;</p>
   <p>&nbsp;</p>
-
  <p>&nbsp;</p>
+
   <p class="July">&nbsp;</p>
-
  <p>&nbsp;</p>
+
<p>&nbsp;</p>
-
  <p>&nbsp;</p>
+
-
  <p>&nbsp;</p>
+
-
  <p>&nbsp;</p>
+
-
  <p>&nbsp;</p>
+
-
  <p>&nbsp;</p>
+
-
  <hr />
+
-
   <p class="July">reference:</p>
+
-
  <p>[1]</p>
+
-
  <p>&nbsp;</p>
+
</div>
</div>
<div id="apDiv4">
<div id="apDiv4">
-
   <table width="610" border="0" cellspacing="0" cellpadding="0">
+
   <p class="clickteam">In order to investigate the extent to which laboratories  understand biosafety issues in regard to antibiotic use, we have carried out a  survey involving about 150 participants (including  researchers from laboratories in the College of Life sciences and College of  Chemistry and Molecular Engineering in Peking University, and employees at a  few sequencing companies) who responded to a series  of questions related with treatment of antibiotic-resistant bacteria in the  laboratory. (For the majority of the participants, who are non-English  speakers, a Chinese version of the questionnaire was provided so that  difficulties in understanding survey questions were minimized.)<br />
 +
    According to the responses given by the  number of participants who have responded, it may be concluded that, in  general, laboratory researchers are aware of potential safety issues related  with the use of antibiotic and resistance genes, but the level of awareness is  far from sufficient for restricting laboratory work in a way that minimizes  possible hazards as a consequence of microbes’ antibiotic resistance.<br />
 +
    The first few questions look into the extent to which  antibiotics and antibiotic-resistant bacteria (ARB) are employed in laboratory  research. It may be seen that over eighty percent of laboratories use ARB for  at least half of their experiments (Q2), and that approximately one fifth of  them use bacteria with multi-antibiotic resistance (Q3). Therefore, there  exists a large pool of antibiotic resistance that is foreseeable threats to the  environment.<br />
 +
  Question 2</p>
 +
  <p class="clickteam"><img src="../../human practice/PwekingR hp Q2.png" width="500" height="282" hspace="50" /></p>
 +
  <p class="clickteam"><br />
 +
  Question 3</p>
 +
  <p class="clickteam"><img src="../../human practice/PekingR hp Q3.png" width="500" height="385" hspace="50" /><br />
 +
  </p>
 +
  <table border="0" cellspacing="0" cellpadding="0" width="397">
     <tr>
     <tr>
-
       <th colspan="4" bgcolor="#E9FEF0" scope="col"><hr /></th>
+
       <td width="359" nowrap="nowrap" class="clickteam"><br />
 +
        A.Mostly    multi-antibiotic resistant(2.56%) </td>
 +
      <td width="38"><p>&nbsp;</p></td>
     </tr>
     </tr>
     <tr>
     <tr>
-
       <th colspan="4" bgcolor="#E9FEF0" class="July" scope="row">Introduction</th>
+
       <td width="359" nowrap="nowrap"><p align="left" class="clickteam">B.Half    are multi-antibiotic resistant(17.95%)</p></td>
 +
      <td width="38"><p>&nbsp;</p></td>
     </tr>
     </tr>
     <tr>
     <tr>
-
       <th colspan="4" bgcolor="#E9FEF0" scope="row"><p class="mainbody">&nbsp;</p>
+
       <td width="397" nowrap="nowrap" colspan="2"><p align="left" class="clickteam">C.Only    a few are multi-antibiotic resistant(46.15%)</p></td>
-
        <p class="mainbody"><strong>This year, a  strain of E coli, which is never seen before and more virulent variant of the  bacterium ,spreading across Europe from  Germany to 10 countries. By 2 June,2011, through eating contaminated vegetables,  18 people have died and more than 2,000 have been infected. As reported, the  new strain appeared likely to be resistant  to common antibiotics<a href="http://www.guardian.co.uk/world/2011/jun/02/e-coli-strain-previously-unseen">[1]</a></p>
+
-
        <p class="mainbody"><br />
+
-
      Many people  believe that <strong class="main">the abuse of antibiotic causes the spread of antibiotic resistance bacterium; however, some researchers  believe that <strong class="main">the lab work also takes  an important role in this process. Our human practice focuses on <strong class="main">the treatment of useless or excrescent  antibiotic resistance bacterium</strong> and <strong class="main">possible  solution of the spread of antibiotic resistance bacterium</strong>. And put our  further considerations to <strong> <span class="main">the challenge</span></strong>made  by the antibiotic resistance bacterium to<strong><span class="main"> the synthetic biology</span></strong>.</p>
+
-
      <p class="mainbody">&nbsp;</p></th>
+
     </tr>
     </tr>
     <tr>
     <tr>
-
       <th colspan="4" bgcolor="#E9FEF0" scope="row"><hr /></th>
+
       <td width="359" nowrap="nowrap"><p align="left" class="clickteam">D.Almost    none(33.33%)</p></td>
 +
      <td width="38"><p>&nbsp;</p></td>
     </tr>
     </tr>
 +
  </table>
 +
  <p class="clickteam">The  next set of questions investigates whether used or unwanted ARB is  appropriately processed in laboratories.<br />
 +
    The  respondents all showed adequate levels of understanding in issues concerning  possible threats induced by abandoned ARB in the laboratory. Almost equal  proportions of respondents pointed out one of the four major consequences,  respectively(Q9). Unfortunately, statistics revealed that over one third of the  respondents reported that used ARB is never or only occasionally processed in  safe and professional ways, and that a considerable portion of them has no  special attention paid to the issue (Q5). Besides, results for Question 6 indicated  that very few (&lt;3%) laboratory researchers have been clearly informed of how  laboratory waste should be processed in their department/organization. Even if  they have somehow been informed, they did not pay much attention because they believed  that laboratory waste is being appropriately processed. It is interesting that  though people know that something like this may have negative effect on our  life, they believe that there will be someone else to be responsible for such  things. To make matters worse, more than half of the laboratories directly  dispose of materials that have been in direct contact with microbes, while some  others care little about the matter (Q8). This further adds to the potential  danger of pollution and transfer of antibiotic resistance to microbes in the  environment. Thus it seems that what is more urgent is not informing  researchers of potential safety hazards of ARB but how to strictly and  effectively regulate laboratory procedures to prevent these hazards. Most researchers  know the consequences of their behavior, but few would take the time and effort  to implement the right measures, probably because public health and environment  have not yet experienced crises of sufficiently alarming levels, which we  strongly wish, of course, to avoid.<br />
 +
  Question 5</p>
 +
  <p class="clickteam"><img src="../../human practice/PekingR hp Q5.png" width="500" height="426" hspace="50" /><br />
 +
  </p>
 +
  <table border="0" cellspacing="0" cellpadding="0" width="521">
     <tr>
     <tr>
-
       <th colspan="4" bgcolor="#E9FEF0" scope="row"><p class="July">Current Situation</p></th>
+
       <td width="521" nowrap="nowrap" class="clickteam"><br />
 +
        A.Almost    always discard directly or pour into sewage(15.91%) </td>
     </tr>
     </tr>
     <tr>
     <tr>
-
      <th width="159" bgcolor="#E9FEF0" scope="row">&nbsp;</th>
+
       <td width="521" nowrap="nowrap"><p align="left" class="clickteam">B.Usually    discard directly and occasionally process them properly(22.73%)</p></td>
-
       <td width="145" bgcolor="#E9FEF0">&nbsp;</td>
+
-
      <td width="147" bgcolor="#E9FEF0">&nbsp;</td>
+
-
      <td width="159" bgcolor="#E9FEF0">&nbsp;</td>
+
     </tr>
     </tr>
     <tr>
     <tr>
-
       <th bgcolor="#E9FEF0" scope="row">&nbsp;</th>
+
       <td width="521" nowrap="nowrap"><p align="left" class="clickteam">C.Usually    process them properly but occasionally discard directly(21.59%)</p></td>
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
     </tr>
     </tr>
     <tr>
     <tr>
-
       <th bgcolor="#E9FEF0" scope="row">&nbsp;</th>
+
       <td width="521" nowrap="nowrap"><p align="left" class="clickteam">D.Always    properly process them separately with other waste(23.86%)</p></td>
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
     </tr>
     </tr>
     <tr>
     <tr>
-
      <th colspan="4" bgcolor="#E9FEF0" scope="row"><hr /></th>
+
       <td width="521" nowrap="nowrap"><p align="left" class="clickteam">E.No    special attention has been paid(15.91%)</p></td>
-
    </tr>
+
-
    <tr>
+
-
      <th colspan="4" bgcolor="#E9FEF0" class="July" scope="row">CAUSE</th>
+
-
    </tr>
+
-
    <tr>
+
-
      <th bgcolor="#E9FEF0" scope="row">&nbsp;</th>
+
-
       <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
    </tr>
+
-
    <tr>
+
-
      <th bgcolor="#E9FEF0" scope="row">&nbsp;</th>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
    </tr>
+
-
    <tr>
+
-
      <th bgcolor="#E9FEF0" scope="row">&nbsp;</th>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
    </tr>
+
-
    <tr>
+
-
      <th colspan="4" bgcolor="#E9FEF0" scope="row"><hr /></th>
+
-
    </tr>
+
-
    <tr>
+
-
      <th colspan="4" bgcolor="#E9FEF0" class="July" scope="row">SOLUTIONS</th>
+
-
    </tr>
+
-
    <tr>
+
-
      <th bgcolor="#E9FEF0" scope="row">&nbsp;</th>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
    </tr>
+
-
    <tr>
+
-
      <th bgcolor="#E9FEF0" scope="row">&nbsp;</th>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
    </tr>
+
-
    <tr>
+
-
      <th bgcolor="#E9FEF0" scope="row">&nbsp;</th>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
    </tr>
+
-
    <tr>
+
-
      <th bgcolor="#E9FEF0" scope="row">&nbsp;</th>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
-
      <td bgcolor="#E9FEF0">&nbsp;</td>
+
     </tr>
     </tr>
 +
  </table>
 +
  <p class="clickteam">Question 6</p>
 +
  <p class="clickteam"><img src="../../human practice/PekingR hp Q6.png" width="500" height="253" hspace="50" /><br />
 +
    <br />
 +
    Question 8</p>
 +
  <p class="clickteam"><img src="../../human practice/PekingR hp Q8.png" width="500" height="360" hspace="50" /><br />
 +
    <br />
 +
    Question 9</p>
 +
  <p class="clickteam"><img src="../../human practice/PekingR hp Q9.png" width="590" height="394" /><br />
 +
    <br />
 +
    In the final part of our survey, we  try to look at the attitudes towards possible approaches to ensure biosafety  related to ARB. Most respondents chose to employ proper procedures for  processing used microbes in the laboratory rather than use special plasmids  that minimize HGT(Q12). This is in fact a more rational choice as adopting  special plasmids may lower researchers’ awareness of HGT and give rise to new  threats. As to whether the government should implement new policies to regulate  the processing of used ARB, most agreed, but some showed opposition(Q13)  contending that it might be troublesome in determining the details and that  still it would be difficult to make the policies work: the government is  unlikely supervise the treatment of RAB every minute. Besides, we also wander  whether the government will run the risk of impeding research progress by heavily  punishing laboratories for violating these policies.<br />
 +
    Question 12<br />
 +
    <img src="../../human practice/PekingR hp Q12.png" width="500" height="261" hspace="50" /><br />
 +
    Question 13</p>
 +
  <p class="clickteam"><img src="../../human practice/PekingR hp 13.png" width="500" height="290" hspace="50" /><br />
 +
    <br />
 +
    In conclusion, we would like to say  that the regulation of antibiotics and ARB use is a matter much more complex  than previously estimated. First of all, it is hard to accurately predict what  exactly happens after HGT takes place, i.e., whether HGT confers the  environment with genes that are useful or harmful to humans. Second, the  establishment of regulations on ARB use and waste processing in different  countries and regions will certainly encounter obstacles due to several  concerns including financial support. Third, even if detailed and strict  procedures are established, laboratories may not be able to discipline  themselves and adhere to the standards. As we have seen above, the problem lies  not in the understanding, but rather in the attitudes and determination to  fight against the abuse and careless treatment of ARB. Besides, as current  trends imply that an increasing number of participants without professional  backgrounds in biology are involved in synthetic biology research, more  challenges are posed to the insurance of biosafety. Professional researchers  themselves may not strictly adhere to laboratory rules and restrictions, let  alone non-professional participants.<br />
 +
    However, nothing  should become a reason for us not to battle against the public health hazards  caused by ARB. We cannot afford to wait for greater outbreaks of superbugs or  antibiotic-resistant pathogen infections before we build up our defense. We  strongly suggest that special agencies or departments funded by the government  be set up to collect and process used ARB in the laboratory. Laboratories  should make it a rule to separate all used microbes and materials that have  been in direct contact with bacteria or their DNA/RNA from other waste and hand  them over to the ARB processing agency. They may also process waste by  themselves, but must ensure that all of them are sterilized or treated with  strong digestive solutions to break up the antibiotic resistance genes.</p>
 +
<p class="clickteam">&nbsp;</p>
 +
</div>
 +
<div id="apDiv5">
 +
  <hr />
 +
  <p class="July">&nbsp;</p>
 +
</div>
 +
<div id="apDiv6">
 +
  <table width="320" height="24" border="0" cellpadding="0" cellspacing="0">
     <tr>
     <tr>
-
       <th bgcolor="#E9FEF0" scope="row">&nbsp;</th>
+
       <th width="85" bgcolor="#000000" scope="col">Prev</th>
-
       <td bgcolor="#E9FEF0">&nbsp;</td>
+
      <th width="50" bgcolor="#E9FEF0" scope="col">1</th>
-
       <td bgcolor="#E9FEF0">&nbsp;</td>
+
       <th width="54" bgcolor="#E9FEF0" scope="col">2</th>
-
       <td bgcolor="#E9FEF0">&nbsp;</td>
+
       <th width="58" bgcolor="#E9FEF0" scope="col">3</th>
 +
       <th width="73" bgcolor="#E9FEF0" scope="col">Next</th>
     </tr>
     </tr>
   </table>
   </table>
-
  <p class="download">&nbsp;</p>
 
</div>
</div>
</body>
</body>
</html>
</html>

Revision as of 16:42, 19 September 2011

Template:Https://2011.igem.org/Team:Peking R/bannerhidden Template:Https://2011.igem.org/Team:Peking R/back2 Template:Https://2011.igem.org/Team:Peking R/Humanpracticebackground 无标题文档

Investigation of Antibiotic Use and

Related Biosafety Issues: What's

happening out there and further.

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

In order to investigate the extent to which laboratories understand biosafety issues in regard to antibiotic use, we have carried out a survey involving about 150 participants (including researchers from laboratories in the College of Life sciences and College of Chemistry and Molecular Engineering in Peking University, and employees at a few sequencing companies) who responded to a series of questions related with treatment of antibiotic-resistant bacteria in the laboratory. (For the majority of the participants, who are non-English speakers, a Chinese version of the questionnaire was provided so that difficulties in understanding survey questions were minimized.)
According to the responses given by the number of participants who have responded, it may be concluded that, in general, laboratory researchers are aware of potential safety issues related with the use of antibiotic and resistance genes, but the level of awareness is far from sufficient for restricting laboratory work in a way that minimizes possible hazards as a consequence of microbes’ antibiotic resistance.
The first few questions look into the extent to which antibiotics and antibiotic-resistant bacteria (ARB) are employed in laboratory research. It may be seen that over eighty percent of laboratories use ARB for at least half of their experiments (Q2), and that approximately one fifth of them use bacteria with multi-antibiotic resistance (Q3). Therefore, there exists a large pool of antibiotic resistance that is foreseeable threats to the environment.
Question 2


Question 3



A.Mostly multi-antibiotic resistant(2.56%)

 

B.Half are multi-antibiotic resistant(17.95%)

 

C.Only a few are multi-antibiotic resistant(46.15%)

D.Almost none(33.33%)

 

The next set of questions investigates whether used or unwanted ARB is appropriately processed in laboratories.
The respondents all showed adequate levels of understanding in issues concerning possible threats induced by abandoned ARB in the laboratory. Almost equal proportions of respondents pointed out one of the four major consequences, respectively(Q9). Unfortunately, statistics revealed that over one third of the respondents reported that used ARB is never or only occasionally processed in safe and professional ways, and that a considerable portion of them has no special attention paid to the issue (Q5). Besides, results for Question 6 indicated that very few (<3%) laboratory researchers have been clearly informed of how laboratory waste should be processed in their department/organization. Even if they have somehow been informed, they did not pay much attention because they believed that laboratory waste is being appropriately processed. It is interesting that though people know that something like this may have negative effect on our life, they believe that there will be someone else to be responsible for such things. To make matters worse, more than half of the laboratories directly dispose of materials that have been in direct contact with microbes, while some others care little about the matter (Q8). This further adds to the potential danger of pollution and transfer of antibiotic resistance to microbes in the environment. Thus it seems that what is more urgent is not informing researchers of potential safety hazards of ARB but how to strictly and effectively regulate laboratory procedures to prevent these hazards. Most researchers know the consequences of their behavior, but few would take the time and effort to implement the right measures, probably because public health and environment have not yet experienced crises of sufficiently alarming levels, which we strongly wish, of course, to avoid.
Question 5



A.Almost always discard directly or pour into sewage(15.91%)

B.Usually discard directly and occasionally process them properly(22.73%)

C.Usually process them properly but occasionally discard directly(21.59%)

D.Always properly process them separately with other waste(23.86%)

E.No special attention has been paid(15.91%)

Question 6



Question 8



Question 9



In the final part of our survey, we try to look at the attitudes towards possible approaches to ensure biosafety related to ARB. Most respondents chose to employ proper procedures for processing used microbes in the laboratory rather than use special plasmids that minimize HGT(Q12). This is in fact a more rational choice as adopting special plasmids may lower researchers’ awareness of HGT and give rise to new threats. As to whether the government should implement new policies to regulate the processing of used ARB, most agreed, but some showed opposition(Q13) contending that it might be troublesome in determining the details and that still it would be difficult to make the policies work: the government is unlikely supervise the treatment of RAB every minute. Besides, we also wander whether the government will run the risk of impeding research progress by heavily punishing laboratories for violating these policies.
Question 12

Question 13



In conclusion, we would like to say that the regulation of antibiotics and ARB use is a matter much more complex than previously estimated. First of all, it is hard to accurately predict what exactly happens after HGT takes place, i.e., whether HGT confers the environment with genes that are useful or harmful to humans. Second, the establishment of regulations on ARB use and waste processing in different countries and regions will certainly encounter obstacles due to several concerns including financial support. Third, even if detailed and strict procedures are established, laboratories may not be able to discipline themselves and adhere to the standards. As we have seen above, the problem lies not in the understanding, but rather in the attitudes and determination to fight against the abuse and careless treatment of ARB. Besides, as current trends imply that an increasing number of participants without professional backgrounds in biology are involved in synthetic biology research, more challenges are posed to the insurance of biosafety. Professional researchers themselves may not strictly adhere to laboratory rules and restrictions, let alone non-professional participants.
However, nothing should become a reason for us not to battle against the public health hazards caused by ARB. We cannot afford to wait for greater outbreaks of superbugs or antibiotic-resistant pathogen infections before we build up our defense. We strongly suggest that special agencies or departments funded by the government be set up to collect and process used ARB in the laboratory. Laboratories should make it a rule to separate all used microbes and materials that have been in direct contact with bacteria or their DNA/RNA from other waste and hand them over to the ARB processing agency. They may also process waste by themselves, but must ensure that all of them are sterilized or treated with strong digestive solutions to break up the antibiotic resistance genes.

 


 

Prev 1 2 3 Next